TAU THERAPY

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20250101089A1
SERIAL NO

18832480

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides a ligand comprising a first binding moiety which binds to tau assemblies, and a second binding moiety which is bound by TRIM21 for use in the treatment of neurodegenerative disease in the cytoplasm of a neuronal cell, wherein the ligand is administered extracellularly.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CAMBRIDGE ENTPR LTDCAMBRIDGE COUNTY ENGLAND

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
JAMES, Leo C Cambridge, GB 3 2
KEELING, Sophie Elizabeth Cambridge, GB 1 0
MCEWAN, William Alexander Cambridge, GB 8 869
MILLER, Lauren Virginia Clare Cambridge, GB 1 0
MUKADAM, Aamir Shehab Cambridge, GB 1 0
SMITH, Annabel Emily Cambridge, GB 1 0
TUCK, Benjamin James Cambridge, GB 1 0
WINTER, Gregory Paul Cambridge, GB 71 7925

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation